← All trials
NCT04561466
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 26, 2019
- Primary completion
- Dec 9, 2021
- Completion date
- Mar 10, 2022
- First posted
- Sep 23, 2020
- Last posted
- Sep 23, 2020
- Enrollment
- 14
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of ParisLead sponsor
- University of ParisReponsible party - principal investigator
- University of ParisCollaborator
- University of ParisStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.